United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

Publisher Name :
Date: 22-Nov-2016
No. of pages: 95
Inquire Before Buying

Notes:

Sales, means the sales volume of 23-Valent Pneumococcal Polysaccharide Vaccine

Revenue, means the sales value of 23-Valent Pneumococcal Polysaccharide Vaccine

This report studies sales (consumption) of 23-Valent Pneumococcal Polysaccharide Vaccine in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- MSD

- Sanofipasteur

- CDIBP

- ...

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Single Dose Vial

- Pre-filled Syringe

- Type III

Split by applications, this report focuses on sales, market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in each application, can be divided into

- For Children (2-10)

- For Person (10-64)

- For The old (=65)

United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016

Table of Contents
United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Report 2016
1 23-Valent Pneumococcal Polysaccharide Vaccine Overview
1.1 Product Overview and Scope of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2 Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
1.2.1 Single Dose Vial
1.2.2 Pre-filled Syringe
1.2.3 Type III
1.3 Application of 23-Valent Pneumococcal Polysaccharide Vaccine
1.3.1 For Children (2-10)
1.3.2 For Person (10-64)
1.3.3 For The old (=65)
1.4 United States Market Size Sales (Value) and Revenue (Volume) of 23-Valent Pneumococcal Polysaccharide Vaccine (2011-2021)
1.4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
1.4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Competition by Manufacturers
2.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Share by Manufactures (2015 and 2016)
2.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Average Price by Manufactures (2015 and 2016)
2.4 23-Valent Pneumococcal Polysaccharide Vaccine Market Competitive Situation and Trends
2.4.1 23-Valent Pneumococcal Polysaccharide Vaccine Market Concentration Rate
2.4.2 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Type (2011-2016)
3.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
3.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
3.4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
4 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume) by Application (2011-2016)
4.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Market Share by Application (2011-2016)
4.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturers Profiles/Analysis
5.1 MSD
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Sanofipasteur
5.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 CDIBP
5.3.2 23-Valent Pneumococcal Polysaccharide Vaccine Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
6 23-Valent Pneumococcal Polysaccharide Vaccine Manufacturing Cost Analysis
6.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States 23-Valent Pneumococcal Polysaccharide Vaccine Market Forecast (2016-2021)
10.1 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue Forecast (2016-2021)
10.2 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Type (2016-2021)
10.3 United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Application (2016-2021)
10.4 23-Valent Pneumococcal Polysaccharide Vaccine Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Classification of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type in 2015
Figure Single Dose Vial Picture
Figure Pre-filled Syringe Picture
Table Application of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure United States Sales Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Application in 2015
Figure For Children (2-10) Examples
Figure For Person (10-64) Examples
Figure For The old (=65) Examples
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales and Growth Rate (2011-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate (2011-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales of Key Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers (2015 and 2016)
Figure 2015 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Figure 2016 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2015 and 2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table 2016 United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Manufacturers
Table United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market 23-Valent Pneumococcal Polysaccharide Vaccine Average Price of Key Manufacturers in 2015
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 3 Manufacturers
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Market Share of Top 5 Manufacturers
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Type in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Market Share by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Share by Type (2011-2016)
Figure Revenue Market Share of 23-Valent Pneumococcal Polysaccharide Vaccine by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Type (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2011-2016)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Application in 2015
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Application (2011-2016)
Table MSD Basic Information List
Table MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Figure MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Sanofipasteur Basic Information List
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table CDIBP Basic Information List
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue, Price and Gross Margin (2011-2016)
Table CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure Manufacturing Process Analysis of 23-Valent Pneumococcal Polysaccharide Vaccine
Figure 23-Valent Pneumococcal Polysaccharide Vaccine Industrial Chain Analysis
Table Raw Materials Sources of 23-Valent Pneumococcal Polysaccharide Vaccine Major Manufacturers in 2015
Table Major Buyers of 23-Valent Pneumococcal Polysaccharide Vaccine
Table Distributors/Traders List
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Production and Growth Rate Forecast (2016-2021)
Figure United States 23-Valent Pneumococcal Polysaccharide Vaccine Revenue and Growth Rate Forecast (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Production Forecast by Type (2016-2021)
Table United States 23-Valent Pneumococcal Polysaccharide Vaccine Consumption Forecast by Application (2016-2021)
  • United States Encephalitis Vaccination Market Report 2017
    Published: 15-Nov-2017        Price: US 3800 Onwards        Pages: 105
    In this report, the United States Encephalitis Vaccination market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report splits the United States market into seven regions: - The West - Southwest - The Middle Atlantic - New England - The South - The Midwest with sales (volume), revenue (value), market share and growth......
  • Global Meningococcal Vaccines Market Research Report 2017
    Published: 15-Nov-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Meningococcal Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Meningococcal Vaccines in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - Chin......
  • Global Encephalitis Vaccination Market Professional Survey Report 2017
    Published: 14-Nov-2017        Price: US 3500 Onwards        Pages: 102
    This report studies Encephalitis Vaccination in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - Novartis - Sanofi - Chengdu institute of biologica - Wuhan ......
  • Global Influenza Vaccine Market Professional Survey Report 2017
    Published: 14-Nov-2017        Price: US 3500 Onwards        Pages: 113
    This report studies Influenza Vaccine in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - GSK - Sinovac - Changsheng - CCBIO - Aleph Biomedical......
  • Global Encephalitis Vaccination Sales Market Report 2017
    Published: 10-Nov-2017        Price: US 4000 Onwards        Pages: 118
    In this report, the global Encephalitis Vaccination market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Encephalitis Vaccination for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe......
  • Global and China Avian Influenza Vaccines Market Research by Company, Type & Application 2013-2025
    Published: 09-Nov-2017        Price: US 2000 Onwards        Pages: 112
    Summary Market Segment as follows: By Type - Type H5 - Type H9 - Other By Application - Chicken - Duck & Goose - Others By Company - Merial - QYH Biotech - DHN - HVRI - CEVA - Elanco (Lohmann ) - Yebio - Zoetis - FATRO - Kyoto Biken - CAVAC - Ringpu Biology - Vaksindo - ChengDu Tecbond - Sind......
  • Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Research Report 2017
    Published: 06-Nov-2017        Price: US 2900 Onwards        Pages: 105
    In this report, the global 23-Valent Pneumococcal Polysaccharide Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of 23-Valent Pneumococcal Polysaccharide Vaccine in these regions, from 2012 to 2022 (forecast), covering ......
  • Global Encephalitis Vaccination Market Research Report 2017
    Published: 31-Oct-2017        Price: US 2900 Onwards        Pages: 119
    In this report, the global Encephalitis Vaccination market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Encephalitis Vaccination in these regions, from 2012 to 2022 (forecast), covering - North America - Europe - ......
  • Global and Regional Avian Influenza Vaccines Market Research Report 2017
    Published: 26-Oct-2017        Price: US 3500 Onwards        Pages: 153
    Summary Avian influenza refers to the disease caused by infection with avian (bird) influenza (flu) Type A viruses. These viruses occur naturally among wild aquatic birds worldwide and can infect domestic poultry and other bird and animal species. Avian flu viruses do not normally infect humans. However, sporadic human infections with avian flu viruses have occurred. Market Segment as follows: By Region - Asia-Pacific - North America......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs